167 related articles for article (PubMed ID: 38557479)
1. The risk of COVID-19 in Cushing's disease is independently related to disease activity (hypercortisolism) and obesity.
M G Mascarenhas-Nakano B; R Correa-Silva S; Fracacio SMR; W Brock P; F Dias R; Binda ESS; Santos-Neto PF; Portari LHC; Sanudo A; Abucham J
Arch Endocrinol Metab; 2024 Mar; 68():e220313. PubMed ID: 38557479
[TBL] [Abstract][Full Text] [Related]
2. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
Osswald A; Deutschbein T; Berr CM; Plomer E; Mickisch A; Ritzel K; Schopohl J; Beuschlein F; Fassnacht M; Hahner S; Reincke M
Eur J Endocrinol; 2018 Aug; 179(2):109-116. PubMed ID: 29875286
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence, etiology and clinical findings of Cushing's syndrome].
Lahera Vargas M; da Costa CV
Endocrinol Nutr; 2009 Jan; 56(1):32-9. PubMed ID: 19627706
[TBL] [Abstract][Full Text] [Related]
4. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
5. Imaging cerebral microbleeds in Cushing's disease evaluated by quantitative susceptibility mapping: an observational cross-sectional study.
Jiang H; Yang W; Sun Y; Yan F; Sun Q; Wei H; Bian LG
Eur J Endocrinol; 2021 Apr; 184(4):565-574. PubMed ID: 33730688
[TBL] [Abstract][Full Text] [Related]
6. [Cushing's syndrome: special issues].
Goñi Iriarte MJ
Endocrinol Nutr; 2009 May; 56(5):251-61. PubMed ID: 19627746
[TBL] [Abstract][Full Text] [Related]
7. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.
Clayton RN; Raskauskiene D; Reulen RC; Jones PW
J Clin Endocrinol Metab; 2011 Mar; 96(3):632-42. PubMed ID: 21193542
[TBL] [Abstract][Full Text] [Related]
8. Cushing's syndrome in multiple endocrine neoplasia type 1.
Simonds WF; Varghese S; Marx SJ; Nieman LK
Clin Endocrinol (Oxf); 2012 Mar; 76(3):379-86. PubMed ID: 21916912
[TBL] [Abstract][Full Text] [Related]
9. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission.
Pupier E; Santos A; Etchamendy N; Lavielle A; Ferriere A; Marighetto A; Resmini E; Cota D; Webb SM; Tabarin A
Front Endocrinol (Lausanne); 2022; 13():934347. PubMed ID: 36004342
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic
Detomas M; Altieri B; Schlötelburg W; Appenzeller S; Schlaffer S; Coras R; Schirbel A; Wild V; Kroiss M; Sbiera S; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2021; 12():731579. PubMed ID: 34489873
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing's disease: a monocentric experience in Southern Italy.
Ragonese M; Giuffrida G; Alessi Y; Giandalia A; Giovinazzo S; Cotta OR; Certo R; Casablanca R; Ferraù F; Cannavò S
J Endocrinol Invest; 2023 Aug; 46(8):1711-1715. PubMed ID: 36708457
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Viecceli C; Mattos ACV; Costa MCB; de Melo RB; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2022; 13():1017331. PubMed ID: 36277689
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
[TBL] [Abstract][Full Text] [Related]
14. Impact of Cushing's syndrome on the gonadotrope axis and testicular functions in men.
Papadakis GE; de Kalbermatten B; Dormoy A; Salenave S; Trabado S; Vieira-Pinto O; Richa C; Kamenicky P; Chanson P; Maione L; Pitteloud N; Young J
Hum Reprod; 2023 Dec; 38(12):2350-2361. PubMed ID: 37742130
[TBL] [Abstract][Full Text] [Related]
15. The incidence of Cushing's disease: a nationwide Swedish study.
Ragnarsson O; Olsson DS; Chantzichristos D; Papakokkinou E; Dahlqvist P; Segerstedt E; Olsson T; Petersson M; Berinder K; Bensing S; Höybye C; Edén Engström B; Burman P; Bonelli L; Follin C; Petranek D; Erfurth EM; Wahlberg J; Ekman B; Åkerman AK; Schwarcz E; Bryngelsson IL; Johannsson G
Pituitary; 2019 Apr; 22(2):179-186. PubMed ID: 30799512
[TBL] [Abstract][Full Text] [Related]
16. Paediatric Cushing's disease: Epidemiology, pathogenesis, clinical management and outcome.
Ferrigno R; Hasenmajer V; Caiulo S; Minnetti M; Mazzotta P; Storr HL; Isidori AM; Grossman AB; De Martino MC; Savage MO
Rev Endocr Metab Disord; 2021 Dec; 22(4):817-835. PubMed ID: 33515368
[TBL] [Abstract][Full Text] [Related]
17. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Chabre O
Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of the disease-specific QOL-CD quality of life questionnaire for patients with Cushing's disease.
Cusimano MD; Huang TQ; Marchie A; Smyth HS; Kovacs K
Neurosurg Focus; 2020 Jun; 48(6):E4. PubMed ID: 32480368
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations.
Belaya Z; Golounina O; Melnichenko G; Tarbaeva N; Pashkova E; Gorokhov M; Kalashnikov V; Dzeranova L; Fadeev V; Volchkov P; Dedov I
Endocrine; 2021 Apr; 72(1):12-19. PubMed ID: 33713312
[TBL] [Abstract][Full Text] [Related]
20. Paediatric Cushing's disease: long-term outcome and predictors of recurrence.
Savage MO; Ferrigno R
Front Endocrinol (Lausanne); 2024; 15():1345174. PubMed ID: 38318299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
